Lately, YY1 was found as a novel target for diabetic nephropathy orchestrated renal fibrosis [33], suggesting decreasing YY1 expression was beneficial for diabetic nephropathy treatment, which offered us insight for diminish YY1 expression in HCC cells. This evidence concerns the gene YY1 and diabetic kidney disease.